Overview

Androgenic Profile Following Controlled Ovarian Stimulation

Status:
Unknown status
Trial end date:
2020-01-01
Target enrollment:
0
Participant gender:
Female
Summary
In this study the investigators will try to discover whether there is a difference for any of the stimulation preparations - recombinant FSH + recombinant LH (pergoveris & luveris) vs. human menopausal gonadotropin (menopur) during GnRH-antagonist cycles in the meaning of androgenic hormones profile. The study question is whether using recombinant LH will result in different follicular hormonal milieu, serum endocrine profile or IVF outcomes than using highly purified urinary gonadotropins with hCG mimicking LH activity.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Sheba Medical Center
Treatments:
Menotropins
Criteria
Inclusion Criteria:

- Infertile women between 20-40 years of age

- BMI 19-35

- undergoing their 1-4 IVF cycle

Exclusion Criteria:

- Suspected PCOS

- History of OHSS

- Patients who had a chronic illness or were receiving chronic medical treatment